Related Experiment Videos
[Memory function of patients with cerebral arteriosclerosis evaluated by Rivermead behavioural memory test]
Hua Xi Yi Ke Da Xue Xue Bao = Journal of West China University of Medical Sciences = Huaxi Yike Daxue Xuebao
|June 1, 1993
Summary
Cerebral arteriosclerosis patients show significantly higher memory anomalies compared to controls. The Rivermead Behavioural Memory Test effectively identifies memory decline, proving valuable for assessing cognitive function in this population.
Area of Science:
- Neurology
- Cognitive Science
- Gerontology
Background:
- Cerebral arteriosclerosis is a condition affecting blood vessels in the brain.
- Memory impairment is a common symptom, but its assessment can be challenging.
- The Rivermead Behavioural Memory Test (RBMT) is a tool designed to evaluate everyday memory functioning.
Purpose of the Study:
- To evaluate the effectiveness of the Rivermead Behavioural Memory Test (RBMT) in identifying memory deficits in patients with cerebral arteriosclerosis.
- To compare the memory performance of patients with cerebral arteriosclerosis to a healthy control group.
- To explore the relationship between brain damage, assessed via CT scans, and memory decline.
Main Methods:
- A cohort of 142 patients diagnosed with cerebral arteriosclerosis was assessed.
- The Rivermead Behavioural Memory Test (RBMT) was administered to all participants and a control group.
- Brain CT scans were utilized to evaluate the extent of brain damage.
- Statistical analyses were performed to compare scores between groups and correlate findings with CT results.
Main Results:
- Patients with cerebral arteriosclerosis exhibited significantly higher rates of abnormal screening scores compared to the control group (P < 0.01).
- Significant differences in RBMT scores were observed across most test items between patients and controls (P < 0.05), excluding picture and face recognition.
- A correlation was identified between brain damage evident on CT scans and behavioral memory decline.
- A notable proportion of the control group also scored low on the RBMT, indicating its sensitivity to memory deficits.
Conclusions:
- The Rivermead Behavioural Memory Test (RBMT) is a sensitive tool for detecting memory decline in individuals with cerebral arteriosclerosis.
- The test demonstrates practical utility in China for assessing memory impairments associated with cerebrovascular conditions.
- Findings support the use of RBMT in clinical settings for early identification and management of cognitive issues in cerebral arteriosclerosis patients.